转录基因分析和机器学习建模识别了超性心肌病的新生物标志物和遗传特征
Feng Zhang1, Chunrui Li2, Lulu Zhang1
1Department of Intensive Care Unit, People's Hospital of Linquan County, Linquan, China.
Frontiers in genetics
|July 2, 2025
概括
生物信息学发现了超性心肌病 (HCM) 的新生物标志物. 一个12基因的签名准确地诊断HCM,提高对其分子机制和免疫细胞参与的理解.
科学领域:
- 心血管生物学 心血管生物学
- 生物信息学是一种生物信息学.
- 基因组学就是基因组学.
背景情况:
- 增高性心肌病变 (HCM) 是一种复杂的遗传性心脏病.
- 了解分子机制和确定可靠的HCM生物标志物对于诊断和治疗至关重要.
研究的目的:
- 使用生物信息学识别超性心肌病 (HCM) 的新型分子生物标志物.
- 描述HCM中的分子机制和免疫细胞透模式.
- 开发HCM的预测诊断模型.
主要方法:
- 分析了HCM患者和健康对照组的RNA测序数据.
- 进行了差异基因表达分析,基因本体学 (GO) 和基因和基因组的京都百科全书 (KEGG) 丰富分析.
- 机器学习算法用于构建和验证预测诊断签名.
主要成果:
- 鉴定了271个差异表达基因 (DEGs),这些基因在关键的生物通路中被丰富.
- 在HCM心肌组织中观察到不同的免疫细胞透模式.
- 一个强大的12基因诊断签名在培训和验证队列中表现出高的预测性能.
结论:
- 生物信息学分析成功地确定了HCM中的DEG和免疫模式.
- 开发的12个基因签名为准确的HCM诊断提供了有前途的工具.
- 这项研究促进了对HCM分子基础和潜在治疗点的理解.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
64
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
64
Cardiomyopathy I: Introduction and Classification
71
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
71


